Featured Session: Biobanks in China: Resources and Harmonization
Presented by: Ti He, NATIONAL ENGINEERING CENTER FOR BIOCHIP, SHANGHAI
About the Session:
China has the largest population of patients, and the latest health reform encourages even more admissions to hospitals, however, potential resources for clinical research have been ignored for a long time. The boom of the pharmaceutical industry and the progress of biomedical studies in China necessitate the use of the clinical samples. In recent years, biobanks have emerged from various hospitals across China. While such biobanks provide access to clinical samples, there remain problems to solve down the road, especially the harmonization of procurement standards. Gain insights on increasing procurement opportunities, including how to:
• Establish key partnerships within the industry to facilitate clinical research
• Gain access to unique samples and cell lines
• Address procurement standardization challenges
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment